ARCHIVES

Senate Approves $47 Million For More AIDs Drugs

This article is from The Cancer Letter archive.

Vol. 12 No. 36 | September 19, 1986

Download PDF Visit The Full Archive

Related Articles

LAK –IL-2 Studies Continue, Moertel Editorial Blasted

March 13, 1987

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

June 21, 2013

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

Prevention Trials Should Get More Funding, Coltman Says.

May 18, 2001

Obese Men More Likely To Have Aggressive Tumors

February 27, 2004

Avon Awards $16.2 Million To Cancer Centers, Others.

April 6, 2001